Search Results

240 results for mpr

The Sweet Dividend Alone Makes KO Stock Worth Another Look

Strategic steps Coca-Cola management is taking makes KO stock a viable investment especially as the global economy may be slowing down

3 High-Yield Monthly Dividend Stocks to Buy

These three monthly dividend stocks have impressively high yields that will be appealing to any income investor.

4 Oil and Gas Stocks to Play the Recent Rally

ConocoPhillips (NYSE:COP), Cabot Oil & Gas Corporation (NYSE:COG), Parker Drilling Company (NYSE:PKD) and QEP Resources Inc (NYSE:QEP) are looking like strong bullish opportunities.

4 Oil and Gas Stocks to Play the Recent Rally

ConocoPhillips (NYSE:COP), Cabot Oil & Gas Corporation (NYSE:COG), Parker Drilling Company (NYSE:PKD) and QEP Resources Inc (NYSE:QEP) are looking like strong bullish opportunities.

4 Tech Stocks With Long-Term Bearish Signals

NFLX, WATT, HIMX and SMCI are clearly bad news for tech bulls…but could present significant profit opportunities to bears.

3 Niche REITs Paying Big Dividends

When it comes to REITs, specialized stocks pay the big dividends. Here are 3 little-talked-about REITs to buy today.

3 Energy Stocks to Buy Thanks to Canada & Mexico

A import war is starting to brew, and it’ll benefit the refineries in the Gulf Coast. Jump on board with these three energy stocks to…

Dream IPOs: The 3 Companies I Would Love to See Go Public

The best companies to go public are those businesses investors find interesting and worth holding for the long haul. 

MKR Crypto Defies Market Turbulence With 30% Gain on the Week

The MKR crypto is coming into the spotlight with its 30% gains on the week. The token is far and away the best-performing asset right…

3 Energy Stocks to Buy in the TradeSmith ‘Green Zone’

It’s time to take a look at these three energy stocks to buy, as each one is currently within TradeSmith’s “Green Zone.”

3 Growth Stocks That Also Pay Monthly Dividends: October 2023

With investors possibly facing difficult circumstances in the economy, now’s the time to consider growth stocks that pay monthly dividends.

SPY Tops Option Midday Movers

Options trading at midday saw SPY topping volume action

What Is Dogelon Mars and How Does It Relate to Twitter and Dogecoin?

Dogelon Mars was one of several dog-inspired meme coins that emerged out of Dogecoin’s rise. Is it a buy now that Musk is making moves?

You Are Risking it All if You Buy Dogelon Mars

Dogelon Mars has utility and may slump due to the end of the altcoin season. Besides, its largest holder owns 43% and can now sell…

4 Machinery Stocks to Sell Now

 

7 Growth Stocks That Also Pay Monthly Dividends: December 2023

Income on Autopilot: 7 Monthly Dividend Stocks to Buy for Stability

Wager on these top monthly dividend stocks for secure income and portfolio resilience in 2024, offering robust upside.

MIR Crypto Plunges 50% as the Terra Ecosystem Drags Mirror Protocol Down

The MIR crypto is one of the many Terra ecosystem projects that’s in free fall as a result of UST’s drastic price de-pegging.

3 Meme Coins That Could Explode Before the Crypto Market Reverses

Meme coins are underpriced and ready to surge, barring fundamental headwinds that investors might oppose. Don’t miss on meme coins to buy.

You May Already Own This Powerful Investment

To say inflation is really hot right now is an understatement at best. The abhorred “i” word is plastered all over news sites, TV screens,…

Clover Stock’s Recovery Could Reverse in the Short-Term

With CLOV stock, a better entry point could emerge between now and its next earnings report.

Starbucks Corporation Stock Bulls Ignoring China Risks

There are risks to owning Starbucks stock as SBUX plans to double operations in China while relations with the U.S. turn frostier.

Buy These Cybersecurity Stocks and ETFs to Forget Your Tech Woes

Inside the strong fundamentals in cybersecurity stocks and ETFs. Compare Brokers….

The Good and the Bad News With Biogen Inc Earnings Results

Even before Biogen’s quarterly report, BIIB stock sank after a series of disappointing clinical results. Investors have to weigh in the good and the bad…

10 – 10 of 240 results